Cirrhosis News and Research

Latest Cirrhosis News and Research

Study shows that anti-PTM antibodies are often present in autoimmune mediated liver disease

A recent study published in Frontiers in Medicine described anti-post-translational modification (PTM) antibodies in patients with autoimmune-mediated and cholestatic liver diseases (AILD).

31 Jul 2023

RNF41 protein could be a new therapeutic target against cirrhosis and liver inflammation

The RNF41 protein could be a new therapeutic target in the fight against two chronic liver diseases: cirrhosis and liver inflammation.

28 Jul 2023

COVID-19 treatment: study evaluates ACEi and ARB effects on clinical outcomes

A group of researchers compared the effects of angiotensin-converting enzyme inhibitors (ACEi) and angiotensin II receptor blockers.

27 Jul 2023

Recent progress in infant hepatitis B vaccination efforts in Africa

Researchers report advancements made toward the elimination of mother-to-child transmission of hepatitis B infection.

27 Jul 2023

Study sheds light on the susceptibility of Chinese men to 60 diseases related to alcohol consumption

Recently, a study conducted by researchers from Peking University and Oxford Population Health shed light on the susceptibility of Chinese men to 60 diseases related to alcohol consumption.

25 Jul 2023

Researchers uncover novel targets for treatment of schistosomiasis

The worms that cause schistosomiasis (Schistosoma mansoni) are unusual in several ways, especially the fact that male and female adults must stay paired together throughout their lives for reproduction to be successful.

21 Jul 2023

Extracellular vesicles may drive fibrosis in scleroderma

Extracellular vesicles, responsible for cell-to-cell communication, might be a driver of fibrosis in systemic sclerosis, according to a recent paper in Arthritis and Rheumatology.

21 Jul 2023

Washington University surgeons pioneer robotic liver transplantation

A surgical team from Washington University School of Medicine in St. Louis recently performed the first robotic liver transplant in the U.S. in May at Barnes-Jewish Hospital.

12 Jul 2023

Older age and certain health conditions increase risk of COVID-19 death in boosted individuals

Researchers identify patient groups at a higher risk of death due to COVID-19 among adults who received a second booster dose in England.

12 Jul 2023

Alcohol-related hepatitis hospitalizations increased dramatically during the pandemic

A boom in alcohol sales during the pandemic appears to have had dire consequences for some as hospital admissions for alcohol-related hepatitis, a life-threatening liver inflammation, increased dramatically, according to a study of national hospitalization data.

10 Jul 2023

CRISPR/Cas9-based screening identifies potential therapies for non-alcoholic fatty liver disease

Activation of the NRF2 transcription factor shows promise as a potential treatment approach for non-alcoholic fatty liver disease (NAFLD), a condition associated with oxidative stress and liver damage. By screening FDA-approved drugs, researchers identified six compounds that enhanced NRF2 activity and demonstrated protective effects against oxidative stress and lipid accumulation.

3 Jul 2023

A healthy lifestyle reduces risk of developing severe liver disease

Researchers investigate the correlation between a healthy lifestyle and Life’s Essential 8 scores in new-onset severe non-alcoholic fatty liver disease.

29 Jun 2023

Alcohol use raises the risks of 61 diseases in Chinese men

Alcohol consumption increases the risks of over 60 diseases in Chinese men, including many diseases not previously linked to alcohol, according to a new study by researchers from Oxford Population Health, Peking University, and the Chinese Academy of Medical Sciences. The study is published today in Nature Medicine.

28 Jun 2023

Researchers identify a potential new drug for NASH-related fibrosis

Researchers at the University of California San Diego School of Medicine have led a study to examine a potential new treatment option for patients with nonalcoholic steatohepatitis (NASH)-related fibrosis.

26 Jun 2023

Owlstone Medical presents data demonstrating progress in development of breath biopsy tests for liver cirrhosis and NASH

Owlstone Medical (“Owlstone”), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced new data on the development of novel tests for the detection of liver disease.

22 Jun 2023

Study finds stark racial and ethnic disparities in alcohol-induced mortality among US adults during the pandemic

Alcohol-related deaths rose disproportionately quickly in the US among Black, Hispanic, Asian and American-Indian/Alaska Native populations at the start of the COVID-19 pandemic, new research shows.

21 Jun 2023

Rising alcohol consumption in China linked to increased risk of 61 diseases

The associations between alcohol consumption and the risk of diseases in Chinese adults.

12 Jun 2023

Life-changing procedure using new aortic valve device clears way for patient in need of liver transplant and hip replacement

Janice Couch, 62, a retired pre-school teacher from Grand Rapids, Michigan, is finally physically ready to receive two procedures that stand to change her life, thanks to Henry Ford Health interventional cardiologists who paved the way by implanting a new aortic valve device for the first time in the health system's history.

6 Jun 2023

Combination therapy successfully treats Pasteurella multocida-related invasive infections

Announcing a new article publication for Zoonoses journal. Pasteurella multocida, a Gram-negative, penicillin-sensitive coccobacillus that is frequently a member of the normal respiratory microbiota of different animals, remains a clinically important pathogen with the ability to cause severe disease. Few case reports have involved P. multocida infections without animal bites.

4 Jun 2023

DIALIVE device may be a disease-modifying therapy for patients with acute-on-chronic liver failure

Acute-on-chronic liver failure (ACLF) occurs in 30% of hospitalized cirrhosis patients, leading to over one million deaths worldwide each year.

31 May 2023

Cirrhosis News and Research

Latest Cirrhosis News and Research

Study shows that anti-PTM antibodies are often present in autoimmune mediated liver disease

RNF41 protein could be a new therapeutic target against cirrhosis and liver inflammation

COVID-19 treatment: study evaluates ACEi and ARB effects on clinical outcomes

Recent progress in infant hepatitis B vaccination efforts in Africa

Study sheds light on the susceptibility of Chinese men to 60 diseases related to alcohol consumption

Researchers uncover novel targets for treatment of schistosomiasis

Extracellular vesicles may drive fibrosis in scleroderma

Washington University surgeons pioneer robotic liver transplantation

Older age and certain health conditions increase risk of COVID-19 death in boosted individuals

Alcohol-related hepatitis hospitalizations increased dramatically during the pandemic

CRISPR/Cas9-based screening identifies potential therapies for non-alcoholic fatty liver disease

A healthy lifestyle reduces risk of developing severe liver disease

Alcohol use raises the risks of 61 diseases in Chinese men

Researchers identify a potential new drug for NASH-related fibrosis

Owlstone Medical presents data demonstrating progress in development of breath biopsy tests for liver cirrhosis and NASH

Study finds stark racial and ethnic disparities in alcohol-induced mortality among US adults during the pandemic

Rising alcohol consumption in China linked to increased risk of 61 diseases

Life-changing procedure using new aortic valve device clears way for patient in need of liver transplant and hip replacement

Combination therapy successfully treats Pasteurella multocida-related invasive infections

DIALIVE device may be a disease-modifying therapy for patients with acute-on-chronic liver failure

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Cirrhosis News and Research

Latest Cirrhosis News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in